Award for PharmaMedic’s Managing Director
We are excited to report that PharmaMedic's Managing Director, Dr Malcolm Barratt-Johnson has received a Global Fellow in Medicines Development (GFMD) award from the respected GMDP Academy.
#R&D
Tag
US FDA issues draft guidance on decentralised clinical trials
Decentralised clinical trials (DCTs) are being used increasingly in the pharma industry for clinical research and the US Food and Drug Administration (FDA) has published draft guidance for those carrying out trials at non-traditional investigation sites.
New Integrated Pathology Unit to speed cancer diagnosis
Cancer diagnosis and treatment are set to be accelerated with the opening of England’s first Integrated Pathology Unit (IPU). The new facility will apply pioneering digital imaging and artificial intelligence to pathology, assisting clinical trial research programmes focused on developing tests for cancer.
The 2023 ABPI annual conference focused on growing the Life Sciences
The 2023 annual conference of the UK’s Association of the British Pharmaceutical Industry (ABPI) at the end of April had a theme of Growing the UK as a Global Hub for Life Sciences.
Backing innovation in British biotechnology
What is the future for UK-based biotechnology? This article reviews the financing of, and governmental support for, the sector and considers the potential impact of new technology in the development of the life sciences.
Pioneer plan to support UK research if Horizon Europe talks fail
While the UK science sector remains committed to association with the international research programme Horizon Europe, the British government has announced its own alternative, which would be implemented if negotiations falter.
Support for Life Sciences in UK Spring Budget 2023
The UK’s Spring Budget, announced on 15 March 2023, set out the government’s plans to help businesses, including the life sciences sector. In addition to an enhanced rate of tax relief for loss-making R&D-focused small and medium sized enterprises, companies investing in qualifying main rate plant and machinery can write off the full cost from 1 April 2023 until 31 March 2026 under a 100% First Year Allowance. Read the full Spring Budget.
Windsor Framework returns NI medicines control to UK
The recently announced Windsor Framework seeks to restore Northern Ireland’s position as part of the UK and thereby undo the political, economic and societal challenges brought about by two years under the Northern Ireland Protocol. As over 1,700 pages of EU law will no longer apply in the region, what will be the situation for medicines supply once the deal goes through, and how will greater cooperation with the EU impact research and innovation under Horizon Europe?
UK government launches Science and Technology Framework
As part of its plan to make the UK a science and technology superpower by 2030, the government launched its ‘Science and Technology Framework’ on 6 March 2023.
BIA reassured by Chancellor on life science support
The UK BioIndustry Association (BIA) appears to have won a reprieve on proposed cuts to SME R&D tax credits, via a letter from Chancellor Jeremy Hunt. The policy was introduced in the Government’s Autumn Statement in November 2022, due to take effect in April 2023.